Free Trial

Cadre (NYSE:CDRE) Upgraded by Wall Street Zen to Buy Rating

Cadre logo with Industrials background

Cadre (NYSE:CDRE - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research report issued on Saturday.

Separately, Bank of America cut shares of Cadre from a "buy" rating to a "neutral" rating and decreased their price target for the stock from $45.00 to $38.00 in a report on Friday.

Read Our Latest Research Report on Cadre

Cadre Trading Up 0.3%

Shares of Cadre stock traded up $0.10 on Friday, reaching $34.50. 65,267 shares of the company were exchanged, compared to its average volume of 255,944. The company has a current ratio of 3.01, a quick ratio of 1.96 and a debt-to-equity ratio of 0.65. The firm has a market capitalization of $1.40 billion, a price-to-earnings ratio of 41.57, a price-to-earnings-growth ratio of 1.58 and a beta of 1.36. The stock has a fifty day moving average price of $32.49 and a 200-day moving average price of $33.51. Cadre has a fifty-two week low of $27.07 and a fifty-two week high of $40.28.

Cadre (NYSE:CDRE - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.23 earnings per share for the quarter, beating analysts' consensus estimates of $0.13 by $0.10. Cadre had a net margin of 6.34% and a return on equity of 12.88%. The business had revenue of $130.11 million for the quarter, compared to the consensus estimate of $121.53 million. During the same period last year, the company posted $0.18 EPS. Cadre's revenue for the quarter was down 5.6% on a year-over-year basis. On average, analysts expect that Cadre will post 1.05 EPS for the current year.

Insider Transactions at Cadre

In related news, CEO Warren B. Kanders sold 50,000 shares of the company's stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $31.88, for a total value of $1,594,000.00. Following the transaction, the chief executive officer now directly owns 10,866,192 shares of the company's stock, valued at $346,414,200.96. This represents a 0.46% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last three months, insiders have sold 200,000 shares of company stock valued at $6,735,500. 37.00% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in CDRE. Assetmark Inc. acquired a new position in shares of Cadre during the fourth quarter worth $31,000. Militia Capital Partners LP purchased a new stake in shares of Cadre during the first quarter worth approximately $49,000. State of Wyoming acquired a new position in Cadre in the 1st quarter valued at $69,000. Harel Insurance Investments & Financial Services Ltd. lifted its holdings in shares of Cadre by 37.7% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 4,221 shares of the company's stock valued at $125,000 after buying an additional 1,155 shares during the period. Finally, US Bancorp DE lifted its holdings in Cadre by 10.6% in the fourth quarter. US Bancorp DE now owns 4,178 shares of the company's stock valued at $135,000 after acquiring an additional 400 shares during the period. 43.95% of the stock is currently owned by institutional investors and hedge funds.

Cadre Company Profile

(Get Free Report)

Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.

Recommended Stories

Should You Invest $1,000 in Cadre Right Now?

Before you consider Cadre, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cadre wasn't on the list.

While Cadre currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines